FDA NDC Directory · JSON-LD · Markdown

Lithium Carbonate

NDC 70518-1481 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerREMEDYREPACK INC.
Marketing categoryNew Drug Application (innovator) · App NDA018558
Dosage form / routeTABLET · ORAL
Active ingredientsLITHIUM CARBONATE (300 mg/1)
Marketing started20181006
Package count1

External sources

Source: openFDA. Public-domain (CC0).